Lecture 10 - Pharmacology of Parkinson Disease and Antiepileptic Agents Flashcards

1
Q

List examples of neurodegenerative diseases

A
  • Alzheimer’s disease
  • Parkinson’s disease
  • Prion disease
  • Huntington”s disease
  • spinal muscular atrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define

Parkinson’s disease

A

A disorder of the basal ganglia caused by a deficiency of dopamine, which produces movement disorder. Most common neurodegenerative cause of parkinsonism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define

Parkinsonism

A

A collective clinical syndrome charachterized by tremor, dradykinesia, rigidity, and postural instability. Can be caused by neurotoxins, reserpine, some antipsychotic drugs, corticobasal degeneration, stoke, and PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PD symptoms - preliminary phase

A
  • Fatigue
  • depressive tendencies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PD symptoms - Disease phase

A

Motor symptoms: bradykinesia (slowed movement), postural instability (impaired balance and coordination), rigidity (stiffness of limbs), resting temor (in arms, hands, leg and face)
Cognitive symptoms: habit learning deficit and other deficits but does not affect working memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where is the majority of dopamine synthesized in the brain?

A

Substantia nigra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the name of the reward center of the brain?

A

Ventral tegmental area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can you visualize PD in the brain?

A

Cut a section of the midbrain where a portion of the substantia nigra is visible and look for lack of melanin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Catecholamine (Dopamine) Metabolism

A

Dopamine –> 3-methoxytyramine via Catechol-O-methyltransferase (COMT) OR –> Dihydroxyphenylacetic acid via Monoamine oxidase (MAO) –> via opposite enzyme to homovanilic acid (HVA) which is secreted in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What parts of the brain does dopamine affect?

A

Prefrontal cortex, nucleus accumbens, caudate nucleus, putamen, substantia nigra, ventral tegmental area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What parts of the brain does acetylcholine affect?

A

Cingulate bundle, fornix, septal nuclei, nucleus basalis, pontomesencephalotegmental complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Relationship of DA to ACH in parkinson’s disease

A

Lowered dopamine
Normal acetylcholine relative to the base level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Relationship of DA and ACH in Huntington’s chorea and tourette’s syndrome

A

Lowered acetylcholine
Normal dopamine relative to base level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What enzyme converts L-DOPA to dopamine?

A

DOPA decarboxylase (DDC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

D1 receptor family

A

D1 –> straitum, neocortex
D5 –> hippocampus, hypothalamus
Second messenger systems: increased cAMP via Gs, PIP2 hydrolysis which leads to Ca2+ mobilization and PKC activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

D2 receptor family

A

D2 –> Straitum, substantia nigra, pituitary gland
D3 –> Olfactory tubercle, nucleus accumbens, hypothalamus
D4 –> frontal cortex, medulla, midbrain
Second messenger systems: decreased cAMP via Gi, increased K+ currents, decreased voltage gated Ca2+ current

17
Q

What is Levodopa?

A

Drug that can cross the blood-brain barrier and converts to dopamine to decrease parkinsonian symptoms

18
Q

Pharmacokinetics of levodopa

A
  • Administered orally
  • Well absorbed in the GI tract
  • co-administered with carbidopa (inhibits DDC)
19
Q

What drugs inhibit metabolism od Levodopa and DA?

A
  • Carbidopa - inhibits only peripheral DDC
  • MAO-B inhibitors - irreversible, slegiline and rasagiline
  • COMT inhibitors - tolcapone and enacapone
20
Q

where do dopamine receptor agonists bind?

A

Bind to and stimulate dopamine receptors in basal ganglia

21
Q

List some dopamine receptor agonists

A
  • Bromocriptine (first used, stimulates DA, alpha-adrenergic, and serotonin recpetors)
  • Pramipexole and rapinirole (preferred)
  • Apomorphine (suncutaneously administered)
22
Q

Miscellaneous drugs

Benzotropine (centrally-acting anticholinergic drugs)

Blocks ACH actions in oder to decrease cholinergic activity

A

Benzotropine is a selective M1 muscarinic acetylcholine receptor antagonist. Partially blocks cholinergic activity in the basal ganglia and increases the availability of dopamine by blocking its reuptake and storage

23
Q

Miscellaneous drug

Amantadine

A
  • M2 proton channel blocker, treats flu
  • Increases DA release, blocks reuptake
  • Effective only in early stages of PD
  • Also a weak NMDA-type glutamate receptor antagonist
24
Q

Antiparkinson drug actions

A
  1. drugs that form dopamine
  2. drugs that inhibits metabolism of levodopa or DA
  3. dopamine receptor agonist
  4. miscellaneous drugs
25
Preferred PD treatment - Tremors
- Amantadine or anticholinergic drugs - Rasagiline (MAO-B inhibitor)
26
Preferred PD treatment - Mild-moderate disease
- Dopamine receptor agonist - Levodopa/carbidopa - COMT and MAO-B inhibitors
27
Preferred PD treatment - Advanced disease
- Levodopa/carbidopa - COMT and MAO-B inhibitors - dopamine receptor agonist
28
What causes epilepsy?
Rapid, synchronized, and uncontrolled electrical activity in the brain. Neurons are overactive and exhibit abnormal discharges.
29
Antiepileptic drugs - Barbiturates and benzodiazepines
- Pharmacological effects - sedation and hypnosis - Mechanism of action - Increase the inhibitory efffects of GABA
30
Antiepileptic drugs - Blocakde of sodium channel activity
Carbamazepine, phenyloin, topiramine, lamotrigine, valproate, zonisamide
31
Antiepileptic drugs - Gabapentin and pregabalin
Mechanism of action - inhibition of voltage-gated calcium channels, increases GABA concentration
32
Antiepileptic drugs - Tiagabine
Blocks neuronal reuptake of GABA